Equine Product ‘Surpass’ Purchased by Boehringer Ingelheim
Boehringer Ingelheim Vetmedica Inc. (BIVI) recently announced it has purchased the product Surpass (1% diclofenac sodium) from Idexx Laboratories Inc. Surpass will be marketed through the existing animal health distribution channels and